News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Ross Stores stock has delivered a strong run over the last few years, yet …
Sharemaestro market context Trend signal active 52 weeks +98.1%Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Toast stock has delivered a strong 60.1% gain over the past three years. However, the latest valuation checks suggest the shares are not a …
Sharemaestro market context Trend signal started 52 weeks -30.1% · Next-week setup negative 27.0%Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Western Digital (NasdaqGS:WDC) spin off SanDisk outlined a US$93.9b customer backlog at its recent …
Sharemaestro market context Trend signal active 52 weeks +507.6%Camden Property Trust (CPT) has filed a shelf registration for up to 7,250,000 common shares, valued at approximately US$802.865 million, linked to an Employee Stock Ownership Plan. Despite recent short-term share price dips, the company shows steady longer-term returns and trades below analyst targets …
The geothermal stock’s latest move keeps pressure on the tape, with elevated activity but weak technical confirmation.
* Westlake Corporation (WLK [https://seekingalpha.com/symbol/WLK]) declares $0.533/share quarterly dividend [https://seekingalpha.com/pr/20620238-westlake-corporation-declares-quarterly-dividend], 0.6% increase from prior dividend of $0.530. * Forward yield [https://seekingalpha.com/symbol/WLK/dividends/yield?source=news_bullet] 2.68% * Payable Sept. 10; for shareholders of record Aug. 25; ex-div Aug. 25. * See WLK Dividend Scorecard, Yield Chart, & Dividend …
Mercury Systems (MRCY) Q2 Earnings Report Preview: What To Look For Aerospace and defense company Mercury Systems (NASDAQ:MRCY) will be reporting results this Tuesday afternoon. Here's what to look for. Mercury Systems beat analysts' revenue expectations last quarter, reporting revenues of $235.8 million, up …
Permian Basin Royalty Trust (NYSE:PBT) is under scrutiny as an energy income vehicle, with its latest update prompting an examination of how well its energy income is supported by operational execution rather than general market sentiment. The article emphasizes that for royalty trusts, cash …
Why Strategy (MSTR) Shares Are Trading Lower Today What Happened? Shares of bitcoin development company Strategy (NASDAQ:MSTR) fell 3.5% in the afternoon session after index provider MSCI proposed removing the company from its Global Investable Market Indexes, compounding concerns over recent sales of its …
Rocket Lab's stock (RKLB) rose overnight after the company confirmed that the first eight satellites built under its $143 million contract with MDA Space successfully reached orbit. These satellites, part of a 17-platform deal, will support Globalstar’s direct-to-device communications and IoT services. The successful …
Veeva Systems added 5.8% in the latest week and now trades 33.9% above its weekly Trend Line, yet participation remains below average and Relative Strength has not turned positive.
Mesoblast (MESO) has completed patient treatment in its pivotal Phase 3 trial (MSB-DR004) for chronic low back pain associated with degenerative disc disease, treating 350 patients. The trial evaluates rexlemestrocel-L and targets a primary endpoint of durable pain reduction at 12 months. Top-line results …
Mesoblast Limited has completed patient treatment in its phase 3 trial for rexlemestrocel-L, aimed at chronic low back pain associated with degenerative disc disease. The trial enrolled 350 patients and seeks to confirm durable pain reduction as its primary endpoint, with top-line results anticipated …
Search by ticker symbol or company name and select a result to open its chart.